Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell
• Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
CytomX Therapeutics Presented Overview of Conditionally-Activated Antibody-Drug Conjugate Programs Including Next Generation EpCAM-Targeting CX-2051 at World ADC Conference
CytomX Therapeutics, Inc. (Nasdaq: CTMX) today announced that the Company presented advances within its conditionally-activated ADC portfolio, including the next generation EpCAM-ADC, CX-2051, at the World ADC conference taking place September 6-9, 2022, in San Diego, CA.
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
Cowen & Co. Downgrades CytomX Therapeutics to Market Perform
Cowen & Co. analyst Boris Peaker downgrades CytomX Therapeutics (NASDAQ:CTMX) from Outperform to Market Perform.
This Low-Float Stock Jumps Around 148%; Here’s 64 Biggest Movers From Yesterday
Gainers
United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.
Analyst Ratings for CytomX Therapeutics
Analysts have provided the following ratings for CytomX Therapeutics (NASDAQ:CTMX) within the last quarter:
Nasdaq Surges 250 Points; Crude Oil Rises Sharply
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping 250 points following the release of data on initial jobless claims.